Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...

Sabrina Lewandowski woke up one morning 23 years ago with a headache that should have killed her. The cause was a stage four ...

Kanazawa University, report in Nature Communications on how the targeted suppression of lysosome function may lead to brain ...

Glioblastoma multiforme (GBM), commonly referred to ... and has the highest degree of malignancy with the poorest prognosis and survival rates. Despite recent advances in treatment, the prognosis ...

Glioblastoma multiforme (GBM) is a very aggressive and ... Among those who followed the diet, 66.7% had a significantly higher survival rate compared to just 8.3% of those who didn't stick to ...

The global glioblastoma treatment drugs market is on the cusp of transformative growth. With market revenues expected to surge from approximately USD 844.8 million in 2025 to a projected USD 1,470.5 ...

While I was recovering, my glioblastoma diagnosis was confirmed ... device called Optune® for the treatment of glioblastoma multiforme (GBM) and walked me through the risks and benefits.

Despite the progress in our understanding of the process of angiogenesis and the potential of targeting these processes for the treatment of GBM, many challenges remain. Considerations regarding ...

died at home of glioblastoma multiforme brain cancer on March 23, 2025, surrounded by her family. When Love was originally diagnosed in March 2022, she was given a prognosis of 10 to 15 months.

The company also continues development of a novel taxane, TPI 287, with published clinical efficacy data in Glioblastoma Multiforme ... superiority in overall survival, the primary endpoint.

"In this analysis overall survival is comparable between Berubicin ... clinical and radiologic data showing activity in Glioblastoma Multiforme, as well as a favorable safety profile in hundreds ...